MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International Long Term Debt Current 2011-2026 | MTD
Annual Long Term Debt Current Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 M | 29.1 M | 28.5 M | 29.3 M | 30.6 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 28.5 M | 30.5 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.96 | 5.63 % | $ 483 M |  USA |
 |
Castle Biosciences
CSTL
|
1.32 M | $ 19.83 | 3.07 % | $ 575 M | USA |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
CareDx, Inc
CDNA
|
6.52 M | $ 21.82 | 1.77 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 93.06 | 2.26 % | $ 6.28 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 424.0 | -1.1 % | $ 12.2 B | USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 2.53 | 31.09 % | $ 3.37 M | USA |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.29 | 4.89 % | $ 397 M | USA |
 |
NeoGenomics
NEO
|
4.78 M | $ 8.96 | -1.21 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
451 K | $ 18.75 | 0.11 % | $ 420 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
7.64 M | $ 194.24 | -11.64 % | $ 19.1 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 177.62 | -2.23 % | $ 8.8 B | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.21 | 0.18 % | $ 25.8 B |  Niderland |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Personalis
PSNL
|
6.89 M | $ 5.98 | -0.17 % | $ 534 M | USA |
 |
Guardant Health
GH
|
27.7 M | $ 95.7 | 3.73 % | $ 12 B | USA |
 |
Senseonics Holdings
SENS
|
496 K | $ 5.03 | -6.16 % | $ 210 M | USA |
 |
Soleno Therapeutics
SLNO
|
726 K | $ 52.95 | - | $ 2.69 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 124.49 | -0.41 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
79 M | $ 141.88 | 2.29 % | $ 22.6 B | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.95 | -2.5 % | $ 8.63 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 56.85 | -2.89 % | $ 3.4 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.15 | -2.05 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 465.0 | -1.99 % | $ 175 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 254.12 | -1.52 % | $ 21.1 B | USA |
 |
Celcuity
CELC
|
54 K | $ 131.06 | 0.27 % | $ 6.13 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Waters Corporation
WAT
|
31.1 M | $ 355.13 | 1.32 % | $ 21.1 B | USA |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.05 | -2.16 % | $ 1.96 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 187.39 | -1.82 % | $ 20.8 B | USA |